Kim Jason K, Carmody Ian C, Cohen Ari J, Loss George E
Ochsner Clinic Foundation, Department of Surgery, Liver and Kidney Transplant, New Orleans, LA 70121, USA.
Clin Transplant. 2009 Aug-Sep;23(4):571-4. doi: 10.1111/j.1399-0012.2008.00928.x.
Post-transplant malignancy of donor origin is a rare complication of organ transplantation, most likely transmitted as micrometastases within the parenchyma of the donor organ or from circulating tumor cells contained within the organ. Patient survival is dependent upon early diagnoses, and differentiation of the malignancy as of donor or recipient derivation is important in developing a treatment modality. The utilization of fluorescent in situ hybridization chromosome analysis and DNA sequence analysis of the tumor cells can assist in this determination. This case report describes the management of donor transmitted malignant melanoma in a liver graft recipient and a review of the current literature.
供体来源的移植后恶性肿瘤是器官移植的一种罕见并发症,很可能是作为微转移灶在供体器官实质内或从器官内所含的循环肿瘤细胞传播而来。患者的生存取决于早期诊断,并且区分恶性肿瘤是供体还是受体来源对于制定治疗方案很重要。利用荧光原位杂交染色体分析和肿瘤细胞的DNA序列分析有助于做出这一判断。本病例报告描述了肝移植受者中供体传播的恶性黑色素瘤的处理情况,并对当前文献进行了综述。